share_log

IceCure's ProSense Cryoablation Featured In Six Global Studies At 2024 EUSOBI Conference

Benzinga ·  Oct 7 20:18

ICE3 Trial Results Presented By Dr. Kenneth Tomkovich Win EUSOBI Abstract Award; THERMAC Trial Demonstrates 94% Complete Ablation Rate For Breast Cancer With Cryoablation; IceCure Conducted Hands-On Demos With Experts At Lisbon Event

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment